These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3266935)

  • 1. Provocation of a paradoxical growth hormone response to corticotropin-releasing hormone by pretreatment with metoclopramide in patients with acromegaly and normal subjects.
    Nishida S; Matsuki M; Adachi N; Horino M; Tsushima K; Yoneda M; Oyama H; Otsuka R; Kikuoka M; Ogawa Y
    Endocrinol Jpn; 1988 Dec; 35(6):783-9. PubMed ID: 3266935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly.
    Giustina A; Doga M; Bodini C; Bossoni S; Bresciani E; Bussi AR
    Endocr Res; 1993 Dec; 19(4):303-15. PubMed ID: 7508379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
    Utsumi A; Hanew K; Sugawara A; Shimizu Y; Murakami O; Ikeda H; Yoshinaga K
    J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion.
    Nishida S; Matsuki M; Adachi N; Horino M; Yoneda M; Endoh M; Oyama H; Kikuoka M; Otsuka R; Ishii R
    J Clin Endocrinol Metab; 1987 May; 64(5):995-1001. PubMed ID: 3031125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
    Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
    Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to confirm a growth hormone-releasing activity of corticotropin-releasing hormone in acromegaly: comparison with the effects of other hypothalamic hormones.
    Watanobe H; Sasaki S; Takebe K
    Acta Endocrinol (Copenh); 1991 Nov; 125(5):487-90. PubMed ID: 1759537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone secretion in human acromegalic pituitary adenomas: cyclic adenosine monophosphate and protein kinase C responses.
    Ishizuka T; Morita H; Mune T; Daidoh H; Hanafusa J; Yamamoto M; Shibata T; Yasuda K
    Metabolism; 1996 Feb; 45(2):206-10. PubMed ID: 8596491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical responsiveness of growth hormone to corticotropin-releasing factor in acromegaly.
    Pieters GF; Hermus AR; Smals AG; Kloppenborg PW
    J Clin Endocrinol Metab; 1984 Mar; 58(3):560-2. PubMed ID: 6420444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
    Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone.
    Faglia G; Paracchi A; Ferrari C; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1978 May; 8(5):373-80. PubMed ID: 417883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion.
    Corsello SM; Tofani A; Della Casa S; Sciuto R; Rota CA; Colasanti S; Bini A; Barini A; Barbarino A
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ovine corticotrophin-releasing factor and hydrocortisone on growth hormone secretion by pituitary adenoma cells of acromegaly in culture.
    Ishibashi M; Hara T; Tagusagawa Y; Fukushima T; Numata H; Hori T; Yamaji T
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):443-7. PubMed ID: 6332444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Paradoxical" growth hormone secretion in acromegaly: an avian model?
    Harvey S
    J Exp Zool Suppl; 1990; 4():195-9. PubMed ID: 1974792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing hormone inhibition of paradoxical growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics.
    Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Colasanti S; Barini A
    Metabolism; 1992 Sep; 41(9):949-53. PubMed ID: 1355581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.
    Biermasz NR; Smit JW; van Dulken H; Roelfsema F
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):313-9. PubMed ID: 11940042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.